BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2000
View Archived Issues
Genetic basis of preeclampsia identified by Pittsburgh researchers
Read More
BioChem Pharma presents overview of recent company progress
Read More
IGI and Fujisawa collaborate on topical formulations of dermatological product
Read More
Efavirenz tested in combination regimens against HIV-1
Read More
Genentech continues to move products smoothly through the pipeline
Read More
Combination efavirenz, nelfinavir and NRTIs assessed in children with HIV-1
Read More
Alza and Abbott formally terminate merger agreement
Read More
U.S. patent for HCV vaccine granted to Innogenetics
Read More
Generex presents latest results for oral insulin formulation
Read More
Ophidian highlights development efforts for fiscal first quarter
Read More
International research team establishes leptin-brain-bone mass link
Read More
New study will evaluate Remune plus HAART in early-stage HIV
Read More
Enzon describes pegylated prodrugs of antitumor compounds with increased water solubility
Read More
Novel MCP-1 antagonists emerge from Warner-Lambert research
Read More
Baxter acquires rights to Xoma's Neuprex for meningococcemia
Read More
Delta receptor ligands with potential as analgesics under study at AstraZeneca
Read More
Glaxo Wellcome investigates therapeutic potential of biaryl derivatives
Read More
Antiarrhythmic compounds with improved safety synthesized at Mitsui Chemicals
Read More
Takeda files for ED treatment in Europe
Read More
FDA allows NicOx to begin phase I trials of NO-NSAID
Read More
Eisai team identifies promising new selective RARalpha agonist
Read More
Dendreon initiates patient enrollment in phase III prostate cancer study
Read More
Novel CDK4 inhibitor series available for licensing from NIH
Read More
West soon to initiate phase I testing of nasal morphine in U.S.
Read More
Searle initiates survival study of aldosterone antagonist
Read More